°MEQU Wins a Public Tender to Provide Portable Blood and IV Fluid Warming Devices (˚M Warmer System) to The Ministry of Defense of the UK

°MEQU, in cooperation with  UK partner Fenton Pharmaceuticals, has won a public tender to provide portable blood and IV fluid warming devices (˚M Warmer System) to The Ministry of Defence (MOD) of the United Kingdom.

The Ministry of Defence is the government department responsible for implementing the defence policy set by Her Majesty’s Government. The UK regular forces consist of the Royal Navy, British Army, Royal Air Force, and Strategic Command.

The ˚M Warmer System was chosen by the UK MOD as it has been proven to satisfy all the criteria set for their blood and IV warming needs. The system is not only small, light and robust, but also offers easy and fast setup. Most importantly, it delivers warm blood or IV fluids to patients within a few seconds.

Ulrik Krogh Andersen (CEO) commented, “Fluid resuscitation before arriving at a hospital is shown to significantly reduce mortality among severely injured patients. We are glad that the UK MOD chose our ˚M Warmer System to treat their service people. With their choice, we at °MEQU keep up with our mission to improve the survival and recovery rate of patients regardless of where the injury occurs.”

Graham Hill (MD Fenton Pharmaceuticals) commented, ”We are very happy that the UK MOD has chosen the °M Warmer System as the blood and fluid warmer for British troops. We have for quite some time supplied the system to an increasing number of civilian HEMS units, but this confirms that the system is ideal for both civilian and military use.”

˚M Warmer System is currently used both in pre-hospital and in-hospital environments, and ˚MEQU is continuously developing its technology to bring warm blood and IV fluids to more patients.

 

 

Source°MEQU

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.